Skip to content

ARPA-H announces first program launch

ARPA-H announces first program launch ARPA-H has launched its first program, Novel Innovations for Tissue Regeneration in Osteoarthritis, or NITRO. NITRO will explore technologies focused on injectable bone regeneration, injectable cartilage regeneration and replacement joints built from human cells. These minimally invasive technologies could reverse the damage caused by osteoarthritis, which is the third leading…

Read More

Q&A with the NCBIO Clinical Research Forum panel explores clinical trial barriers 

The panel at the NCBIO Clinical Trials Forum comprised moderater Abby Emanuelson, IQVIA's Erin Finot, Ultragenyx's Julie Harrell and Thermo Fisher Scientific's Rose Blackburne, M.D.

An expert panel explored the current state of clinical trial participation at the NCBIO Clinical Research Forum held Tuesday, Nov. 29. Panelists talked about ways to lower the barriers that stop patients from participating in clinical trials and discussed strategies for achieving diversity. They also explored the role of patient advocates and gave special consideration to efforts focused on rare diseases. 

Read More